Back to Results
First PageMeta Content
Antifungals / Antiprotozoal agents / Clinical research / Euglenozoa / Visceral leishmaniasis / Leishmaniasis / Amphotericin B / Miltefosine / Cutaneous leishmaniasis / Medicine / Microbiology / Biology


Articles Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial Shyam Sundar, Prabhat Kumar Sinha, Madhukar
Add to Reading List

Document Date: 2011-11-28 18:59:53


Open Document

File Size: 258,69 KB

Share Result on Facebook

City

Hyderabad / Montreal / Bern / Mumbai / Patna / Helsinki / /

Company

KP NV / DKV SA PK / GlaxoSmithKline / KN NV / MV / Paladin Labs / Role / Oracle / Médecins Sans Frontières / Vaccine Ltd. / Gilead Sciences / Rai M. Laboratory / /

Continent

Asia / South America / /

Country

Switzerland / Nepal / Canada / India / United States / /

Currency

USD / /

/

Event

Product Recall / FDA Phase / Product Issues / /

Facility

Rajendra Memorial Research Institute of Medical Sciences / Basel University / Institute of Medical Sciences / Banaras Hindu University / Kala-Azar Medical Research Center of Banaras Hindu University / SAS Institute / /

IndustryTerm

treatment / Online/Comment / control / binomial law / treatment groups / php/clinical-trial-protocols / trial site / perprotocol / system software version / oil immersion / injection site / Online January / car accident / study protocol / combination groups / received travel funds / /

MedicalCondition

HIV / presumptive visceral leishmaniasis / leishmaniasis / hepatitis B / systemic allergic reaction / eliminationof visceral leishmaniasis / chills / Guillain-Barré syndrome / †Urticaria / diabetes / Fever / Vomiting / pancytopenia / Indian epidemic / allergic reaction / kala-azar / hypersensitivity / MS / hypertension / disease / Indian visceral leishmaniasis / Neglected Diseases / Introduction Visceral leishmaniasis / pain / This disease / urticaria / Asian visceral leishmaniasis / Tropical Diseases / visceral leishmaniasis / severe concurrent illness / tuberculosis / /

MedicalTreatment

contraception / Combination drug therapy / intravenous infusion / /

NaturalFeature

Adeline MT / /

Organization

Basel University / World Health Organization / UK Department for International Development / Indian Council of Medical Research / Kala-Azar Medical Research Center / United Nations International Children's Emergency Fund / Data Safety Monitoring Board / Santé Centre / Institute for One World Health / Department of Medicine / United Nations Development Programme / Spanish Agency of International Cooperation for Development / Centre de Recherche Public / Kala-Azar Medical Research Centre / Banaras Hindu University / Varanasi / SAS Institute / Rajendra Memorial Research Institute of Medical Sciences / World Bank / Institute of Medical Sciences / Starr International Foundation in Switzerland / Ethics Committee / /

Person

Farrokh Modabber / Rakesh Arora / Nathalie Strub-Wourgaft / Chandra Shekhar Lal / Deepak Kumar Verma / Sally Ellis / Michel Vaillant / Krishna Pandey / Ben Brahim / Shyam Sundar / /

Position

Prime Minister / independent international auditor / Drug Controller General / Major / trained study nurse / consultant / trial statistician / clinical adviser / /

Product

Asthenia Chills Injection / medroxyprogesterone acetate / dextrose / AmBisome / patients / Paladin / amphotericin B / Medical Research / S0140-6736 / /

ProgrammingLanguage

php / SAS system / /

ProvinceOrState

Bihar / /

Region

north Africa / east Africa / southern Europe / Latin America / south Asia / /

Technology

html / alpha / study protocol / /

URL

www.thelancet.com / http /

SocialTag